Recent Finacing
Recent Raise
Attenua is a clinical-stage biotechnology company developing medicines for chronic respiratory disorders, advancing lead candidate ATA-101—which targets a distinct chronic-cough mechanism—into Phase 2 clinical trials and a broader pipeline.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors